Parvovirus B19-related anemia in an HIV-infected patient: rapid control after production of neutralizing antibodies during highly active antiretroviral therapy.
Arribas
J R
JR
Peña
J M
JM
Echevarría
J E
JE
D000328:Adult; D000740:Anemia / Q000276:immunology / Q000821:virology*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000097:blood; D007075:Immunoglobulin M / Q000096:biosynthesis* / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D010322:Parvoviridae Infections / Q000276:immunology*; D016732:Parvovirus B19, Human
D019380:Anti-HIV Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous